As was previously demonstrated for a sublingual insulin formulation (sublintherapeutics.com/sublin-bv-developing-a-first-in-class-sublingual-insulin-delivery-formulation/)), these in vivo incretin studies clearly show that the sublingual formulation technology can incorporate different drug classes and provide an effective alternative for patients to their daily injections
Heres a table comparing the average monthly cost of brand-name vs compounded GLP-1 medications in the U.S., as of mid-2025: Key Takeaways: Savings range from 60% to 85% when using compounded versions, especially for semaglutide and tirzepatide
Zeng Y, Yang K, Wang F, Zhou L, Hu Y, Tang M, Tang M et al (2016) The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression
Abstract Low back pain (LBP), as a leading cause of disability, is a common musculoskeletal disorder that results in major social and economic burdens